Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Stock
Equities
688076
CNE1000051X5
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.89 CNY | +0.16% | +0.57% | +26.56% |
Sales 2024 * | 1.47B 203M | Sales 2025 * | 2.02B 279M | Capitalization | 12.13B 1.67B |
---|---|---|---|---|---|
Net income 2024 * | 232M 32.02M | Net income 2025 * | 329M 45.41M | EV / Sales 2024 * | 8.25 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.01 x |
P/E ratio 2024 * |
52.3
x | P/E ratio 2025 * |
36.7
x | Employees | 1,545 |
Yield 2024 * |
0.54% | Yield 2025 * |
0.83% | Free-Float | 52.6% |
1 day | +0.16% | ||
1 week | +0.57% | ||
1 month | +1.53% | ||
3 months | +13.26% | ||
6 months | +31.84% | ||
Current year | +26.56% |
Managers | Title | Age | Since |
---|---|---|---|
Zi Quan Tong
CEO | Chief Executive Officer | 54 | 17-08-31 |
Wei Ding
DFI | Director of Finance/CFO | 41 | 23-02-05 |
Biao Liu
CHM | Chairman | 43 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qiang Guo Xu
BRD | Director/Board Member | 60 | 19-05-19 |
Feng Qu
BRD | Director/Board Member | 49 | 19-05-19 |
De Yi Zhao
BRD | Director/Board Member | 61 | 09-04-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 56.89 | +0.16% | 1,091,493 |
24-05-30 | 56.8 | +0.35% | 1,599,684 |
24-05-29 | 56.6 | -.--% | 2,281,133 |
24-05-28 | 56.6 | -0.96% | 907,825 |
24-05-27 | 57.15 | +1.03% | 1,528,187 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.56% | 1.67B | |
+40.73% | 739B | |
+31.66% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.77% | 240B | |
+9.54% | 210B | |
-4.79% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 688076 Stock